Full Text View
Tabular View
No Study Results Posted
Related Studies
Improving the Results of Bone Marrow Transplantation for Patients With Severe Congenital Anemias
This study is currently recruiting participants.
Study NCT00061568   Information provided by National Institutes of Health Clinical Center (CC)
First Received: May 29, 2003   Last Updated: October 24, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Congenital Hemolytic Anemia
Diamond-Blackfan Anemia
Additional conditions recognized in this trial
Anemia
Anemia, Diamond-Blackfan
Anemia, Hemolytic
Anemia, Hemolytic, Congenital
Anemia, Sickle Cell
More general conditions related to this trial
Anemia, Aplastic
Anemia, Hypoplastic, Congenital
Bone Marrow Diseases
Genetic Diseases, Inborn
Hematologic Diseases
Hemoglobinopathies
Red-Cell Aplasia, Pure
Interventions listed in this trial
Radiotherapy
Additional drug interventions recognized in this trial
Alemtuzumab
Sirolimus
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Antibiotics, Antineoplastic
Antifungal Agents
Antineoplastic Agents
Immunologic Factors
Immunosuppressive Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
National Heart, Lung, and Blood Institute (NHLBI)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services